Obsessive-compulsive Disorder
📧 Sign up to get email alerts when something new happens for Obsessive-compulsive Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-05-13Clinical Trial Update: Short and Intensive Treatment of Children and Adolescents With Obsessive-Compulsive Disorder [NA]
A clinical trial entry indicates a short and intensive treatment approach for children and adolescents with obsessive-compulsive disorder is…
-
CLINICAL_TRIALS research · 2025-05-09Clinical Trial Update: Gamified Digital Intervention to Enhance the Efficacy of Exposure Therapy for OCD [NA]
This clinical trial evaluates a gamified digital intervention to enhance exposure therapy for obsessive-compulsive disorder; the study statu…
-
CLINICAL_TRIALS research · 2025-05-08Clinical Trial Update: Interpretation Bias as a Mechanism of Treatment Response in OCD [NA]
This clinical trial investigates whether interpretation bias mediates treatment response in obsessive-compulsive disorder and is currently r…
-
CLINICAL_TRIALS research · 2025-04-25Clinical Trial Update: Comparing Exposure v Imagery Rescripting in People With OCD: a SCED [NA]
King's College London is conducting a clinical trial comparing exposure therapy to imagery rescripting for obsessive-compulsive disorder, cu…
-
CLINICAL_TRIALS research · 2025-04-24Clinical Trial Update: Brain-Oscillation Synchronized Stimulation of the DMPFC [NA]
Clinical trial is currently recruiting to test brain-oscillation synchronized stimulation of the dorsomedial prefrontal cortex for Obsessive…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-04-22Clinical Trial Update: Personalized DBS for OCD Guided by Stereoencephalography Mapping [NA]
A clinical trial exploring personalized deep brain stimulation for obsessive-compulsive disorder, guided by stereoencephalography mapping, i…
-
CLINICAL_TRIALS research · 2025-04-18Clinical Trial Update: An OCD Prevention Programme for at Risk Adults [NA]
A prevention programme for adults at risk of Obsessive-Compulsive Disorder is currently recruiting.
-
CLINICAL_TRIALS research · 2025-04-17Clinical Trial Update: Development of Adaptive Deep Brain Stimulation for OCD [NA]
Clinical trial update on the development of adaptive deep brain stimulation for obsessive-compulsive disorder; the study is currently active…
-
CLINICAL_TRIALS trial_result · 2025-04-17Clinical Trial Update: Development of Adaptive Deep Brain Stimulation for OCD (Phase 1a) [NA]
An adaptive deep brain stimulation trial for Obsessive-Compulsive Disorder is described as ongoing but not recruiting, under Baylor College …
-
CLINICAL_TRIALS research · 2025-04-11Clinical Trial Update: Evaluation of Primary Care Behavioral Health (PCBH) With the Addition of Self-help CBT - A Randomized Multicenter Trial [NA]
A multicenter randomized trial evaluating primary care behavioral health with added self-help CBT is currently recruiting.
-
CLINICAL_TRIALS research · 2025-04-04Clinical Trial Update: Deep Brain Stimulation Surgery for the Treatment of Refractory Obsessive-Compulsive Disorder [NA]
A clinical trial is investigating deep brain stimulation surgery as a treatment for refractory obsessive-compulsive disorder and is currentl…
-
CLINICAL_TRIALS research · 2025-04-02Clinical Trial Update: Ketamine Safety and Tolerability in Psychiatric Inpatient Care (KetGD)
An ongoing inpatient clinical trial evaluating the safety and tolerability of ketamine for psychiatric conditions, with enrollment by invita…
-
CLINICAL_TRIALS research · 2025-03-27Clinical Trial Update: Cortical Stimulation to Treat Obsessive Compulsive Disorder [NA]
A clinical trial update indicates that a cortical stimulation approach for obsessive-compulsive disorder is currently recruiting participant…
-
CLINICAL_TRIALS research · 2025-03-24Clinical Trial Update: Brief-intensive CBT Versus Once-weekly CBT in Anxiety-related Disorders [NA]
A trial comparing brief-intensive CBT to weekly CBT for anxiety-related disorders is currently recruiting at Universitair Ziekenhuis Brussel…
-
CLINICAL_TRIALS research · 2025-03-18Clinical Trial Update: Assess the Utility of a Speech-based Machine Learning Algorithm to Predict Treatment Response to Psychiatric Interventions
A clinical trial update indicates Psyrin Inc. is enrolling participants to test a speech-based machine learning algorithm that aims to predi…
-
FDA approval · 2025-03-13FDA Approved: PAROXETINE — Supplemental Application (NorthStar Rx LLC)
The FDA approved a supplemental application for paroxetine hydrochloride (paroxetine) as a generic product under NorthStar Rx LLC's ANDA.
-
FDA approval · 2025-03-13FDA Approved: FLUVOXAMINE MALEATE — Supplemental Application (Chartwell RX, LLC)
FDA granted approval of a supplemental application for fluvoxamine maleate from Chartwell RX, LLC.
-
CLINICAL_TRIALS research · 2025-03-07Clinical Trial Update: Using Virtual Reality Before Transcranial Magnetic Stimulation for the Treatment of OCD [NA]
A clinical trial is investigating the use of virtual reality before transcranial magnetic stimulation for obsessive-compulsive disorder; the…
-
FDA approval · 2025-02-28FDA Approved: PAROXETINE — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for paroxetine hydrochloride from Zydus Lifesciences Limited, adding regulatory approval for this ge…
-
FDA approval · 2025-02-15FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (XLCare Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Sertraline Hydrochloride from XLCare Pharmaceuticals, Inc., authorizing the generic product.
-
CLINICAL_TRIALS trial_result · 2025-02-14Clinical Trial Update: Internet-delivered CBT for Paediatric OCD [NA]
The trial evaluating internet-delivered cognitive-behavioral therapy for pediatric obsessive-compulsive disorder has completed.
-
CLINICAL_TRIALS trial_result · 2025-02-13Clinical Trial Update: Task Control Circuit Targets for Obsessive Compulsive Behaviors in Children [NA]
A University of Michigan study investigating task control circuit targets for obsessive-compulsive behaviors in children has completed.
-
FDA approval · 2025-02-11FDA Approved: PAROXETINE — Supplemental Application (Padagis US LLC)
FDA approved a supplemental application for paroxetine (Padagis US LLC), updating the labeling to reflect expanded indications for the antid…
-
FDA approval · 2025-01-29FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for sertraline hydrochloride (generic sertraline), authorizing the generic prod…
-
CLINICAL_TRIALS trial_result · 2025-01-28Clinical Trial Update: TMS for Improving Response Inhibition in Adolescents With OCD [NA]
This entry reports the completion and results posting of a trial evaluating transcranial magnetic stimulation to improve response inhibition…